Category Archive

All About Seizures

Pharmaceutical companies need to explain why drug shortages occur in order to prevent them

February 4, 2016

By Deron Hamel Stakeholders would be better positioned to offer solutions to prevent medication shortages if pharmaceutical companies provided public explanations about why shortages happen, says Suzanne Nurse, Epilepsy Ontario’s director of information and client services. Following public consultation in 2014, the Canadian government announced it would be mandating the country’s pharmaceutical manufacturers to publicly…

Focal dyscognitive seizures explored in new video

January 21, 2016

By Deron Hamel A businessman is giving a presentation in a boardroom. Suddenly, he stops midspeech and begins to blankly stare. Then he starts to fidget and wander. One of his colleagues notices something is not right, but she has seen this before. She walks over to the man and slowly begins to guide him…

Action Day 2015 aims to ensure seizure control is available to all Ontarians with epilepsy

October 22, 2015

By Deron Hamel Representatives from community epilepsy agencies across Ontario will be gathering at Queen’s Park on Oct. 27 to meet with MPPs to underscore the importance of controlling seizures for everyone in the province living with epilepsy. Epilepsy Action Day is an annual event where the representatives convene at the Ontario legislature to mobilize…

2,000% price hike on infantile spasms medication ‘predatory behaviour’: Neurologist

September 24, 2015

By Deron Hamel A 2,000-per-cent price hike on a medication to treat infantile spasms is “predatory behaviour” on the part of Questcor Pharmaceuticals, and drug companies could hike prices on other seizure medications if policies aren’t put into place, says pediatric neurologist Dr. Carter Snead. Infantile spasms – also called West syndrome – is a…